Intra-Cellular Therapies
Why Robinhood?
You can watch ITCI and buy or sell other stocks, ETFs, and their options commission-free!About ITCI
Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system.
ITCI Key Statistics
Stock Snapshot
The current Intra-Cellular Therapies(ITCI) stock price is $131.87, with a market capitalization of 14.05B. The stock trades at a price-to-earnings (P/E) ratio of -182.70.
Intra-Cellular Therapies(ITCI) stock opened on 2026-05-09 at —. The price climbed to — and dipped to —.
Intra-Cellular Therapies(ITCI) shares are trading with a volume of 0, against a daily average of 1.9M.
In the last year, Intra-Cellular Therapies(ITCI) shares hit a 52-week high of $131.98 and a 52-week low of $64.09.
In the last year, Intra-Cellular Therapies(ITCI) shares hit a 52-week high of $131.98 and a 52-week low of $64.09.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.